Schizophrenia Support Forum
PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2
Medications
firemonkey
July 31, 2026, 5:13pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
Alto Neuroscience Announces Completion of Enrollment in Phase 2
News on schizophrenia and mental health matters
0
43
February 14, 2026
Phase 2 Trial of LB-102 for Schizophrenia Shows Positive Impact on Cognitive Performance
News on schizophrenia and mental health matters
0
55
March 29, 2026
Tazbentetol for Schizophrenia Shows Symptom Improvement in Phase 2 Trial
Medications
7
119
March 28, 2026
FDA Grants Clearance to Motivista, the First Authorized Treatment for
News on schizophrenia and mental health matters
1
66
October 8, 2026
Phase 1 Clinical Studies Completed: NTX-253 for the Treatment of Schizophrenia
News on schizophrenia and mental health matters
0
42
October 8, 2026